CN1552409A - Medicine composition for preparing canker and preparing method thereof - Google Patents
Medicine composition for preparing canker and preparing method thereof Download PDFInfo
- Publication number
- CN1552409A CN1552409A CNA031371531A CN03137153A CN1552409A CN 1552409 A CN1552409 A CN 1552409A CN A031371531 A CNA031371531 A CN A031371531A CN 03137153 A CN03137153 A CN 03137153A CN 1552409 A CN1552409 A CN 1552409A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- thick paste
- powder
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese medicine in the form of powder for treating gastric ulcer and duodenal ulcer is prepared through decocting astragalus root, white peony root and liquorice root, filtering, concentrating, depositing in alcohol, distilling to remove alcohol, concentrating, mixing with cuttlefish bone powder and famotidine, drying and pulverizing. Its advantages are high cure rate and low cost.
Description
Technical field
The present invention relates to be mainly derived from pharmaceutical composition and the method for making that vegetable material forms.The pharmaceutical composition by diseases such as the treatment gastric ulcer of several Chinese herbal medicine and a kind of compound formation, duodenal ulcers and preparation method thereof of more specifically saying so.
Background technology
The medicine of treatment peptic ulcer and chronic gastritis has Western medicine and Chinese medicine.Gastropine, veytalo tablet, gel aluminum hydroxide etc. are arranged in the Western medicine,, side effect is in various degree arranged after some medicine is used through clinical proof.
Traditional Chinese herbal medicine composite formula has soup sides such as " peony and licorice decoction ", " Unio margarita soup ", and above-mentioned Chinese herbal medicine compositions is original dosage form, and absorption by human body is slower, is unsuitable for treating the emergency case patient and carries out the phase patient.Owing to be that decoction is difficult for preserving, must decoct voluntarily again, time-consuming, bothersome, very inconvenient, take more apparent inconvenience on the road.
In Chinese patent literature, the Chinese medicine composition report of treatment gastric ulcer, duodenal ulcer is more, wherein application number is 95109473.4 patent documentation (publication number CN1143504A, applying date 95.8.21, open day 97.2.26), reported " instant granule for curing gastric ulcer and production technology thereof ".This electuary is made up of the Radix Astragali, Radix Glycyrrhizae, the Radix Paeoniae Alba, Rhizoma Corydalis, Endoconcha Sepiae, Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Sanguisorbae, Radix Et Rhizoma Rhei, Endothelium Corneum Gigeriae Galli, Fructus Crataegi, Fructus Aurantii, the Radix Aucklandiae 12 flavor medical materials, and the ratio of this 12 flavor Chinese crude drug is 7: 6: 5: 5: 3: 3: 4: 1: 4: 3: 2: 2.
Its method for making is at first with Endoconcha Sepiae, Endothelium Corneum Gigeriae Galli, Pseudobulbus Bletillae (Rhizoma Bletillae) three flavor medicines, be ground into the above mixed powder of 120 orders, with the Radix Astragali, Radix Glycyrrhizae, the Radix Paeoniae Alba, Rhizoma Corydalis, Radix Sanguisorbae, Radix Et Rhizoma Rhei, Fructus Crataegi, Fructus Aurantii and the Radix Aucklandiae nine flavor Chinese crude drug 70-90%, the alcohol dipping 12-24 that 4-8 doubly measures hour, filter to get filtrate, with the pure cream of filtrate recycling ethanol to relative density 1.2 (80 ℃ ±).After the alcohol extraction nine flavor medical material is added water 4-8 doubly, decoct filtration in 1-2 hour.Again nine flavor medical materials are added water 4-8 doubly, decoct and filtered to get filtrate in 1-2 hour, merge the filtrate of above-mentioned secondary decocting and be concentrated into the water cream of relative density 1.2 (80 ℃ ±).Get it filled 1 part in powder, 1 part of pure cream+water cream, 0.5 part of mixing granulation of dextrin.At last the medicine grain of making is dried under 60 ℃-80 ℃ condition.This electuary taking convenience, especially on the road, portable to take.The electuary of this patent application is through the clinical proof of taking medicine, its treatment duodenal ulcer obvious effective rate is 70%, gastric ulcer obvious effective rate 67.74%, the obvious effective rate of this electuary treatment duodenal ulcer and gastric ulcer is not high as can be seen, does not report the situation of its duodenal ulcer and gastric ulcer cure rate yet.
Summary of the invention
Purpose of the present invention just is to develop a kind of pharmaceutical composition of new treatment Peptic Ulcers, makes the curative effect of this medicine composite for curing Peptic Ulcers better.
Another object of the present invention is the method that works out the above-mentioned new treatment Peptic Ulcers pharmaceutical composition of preparation.
A kind of pharmaceutical composition for the treatment of ulcer of the present invention contains Radix Astragali 50-80 weight portion, Endoconcha Sepiae 10-35 weight portion, Radix Paeoniae Alba 25-45 weight portion, Radix Glycyrrhizae 25-45 weight portion, famotidine 0.8-1.3 weight portion decocts with water the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae, filtrate concentrates, precipitate with ethanol is removed alcoholic acid concentrated solution, is condensed into thick paste, with thick paste and Endoconcha Sepiae powder and famotidine powder mix homogeneously, the pharmaceutical composition dry, that pulverizing forms.
The pharmaceutical composition of above-mentioned this treatment Peptic Ulcers to be containing Radix Astragali 60-70 weight portion, Endoconcha Sepiae 15-21 weight portion, and Radix Paeoniae Alba 30-40 weight portion, Radix Glycyrrhizae 30-40 weight portion, famotidine 0.8-1.1 weight portion is good.
Said weight portion can be money, two, milligram, gram, jin, kilogram, ton etc.
In this treatment Peptic Ulcers pharmaceutical composition of the present invention, Radix Astragali sweet in the mouth tepor is gone into lung spleen two warps, invigorating the spleen and replenishing QI is arranged, nourish blood and take the photograph the merit of blood, " gold slightly deficient annotate " cloud: " blood of the vital organs of the human body; rely temper to have under one's command entirely " so with Radix Astragali strengthening QI of middle-JIAO, can receive the effect of hemostasis hemopoietic, for our monarch drug also.
The Endoconcha Sepiae salty in the mouth is puckery, the feeble QI temperature, and light weight is a powder, per os is gone into the blood network that stomach directly becomes impaired.Get its puckery property of holding back, convergence blood vessels and stopping blooding are used its saline taste, and softening the hard mass dissipating blood stasis and stop blooding and do not stay the stasis of blood is the good medicine of astringing to arrest bleeding.And this product can be held back sour stomach function regulating relieving gastric hyperacidity to alleviate stomachache, is ministerial drug in the side.
Radix Paeoniae Alba picric acid is slightly cold, can nourishing YIN and benefiting blood, and relieving spasm to stop pain, Radix Glycyrrhizae is sweet flat, also can relieving spasm to stop pain, invigorating the spleen and replenishing QI.Radix Paeoniae Alba sour in the mouth, the gas that gets building is the purest, the Radix Glycyrrhizae sweet in the mouth, it is the thickest to get native gas, and two medicines, 5 usefulness have the wonderful of sour and sweet drugs can transforme into YIN, preserving YIN with astringents and nourishing blood, the effect of relieving spasm to stop pain, " pearl in red water " said: " Radix Paeoniae gets Radix Glycyrrhizae and controls stomachache ".So with it is that Fang Zhongzuo makes also.
Please share by medicine, play the QI invigorating tonifying YIN altogether, the hemostasis hemopoietic, the merit of relieving spasm to stop pain can be treated gastric ulcer, hemorrhage, duodenal ulcer, hemorrhage and various stomach, duodenitis.
The pharmaceutical composition of treatment Peptic Ulcers of the present invention can be made capsule, electuary, various dosage forms such as pill.
Behind above-mentioned thick paste and Endoconcha Sepiae and famotidine and starch mix homogeneously, drying is pulverized encapsulated formation capsule.
The known technology method pressure that above-mentioned thick paste is all known with those skilled in the art is that the nitrogen of 1Mpa-2.5Mpa is carrier gas, and the thick paste that adds an amount of dextrin is spray dried to dissolved granule.
Also can be with above-mentioned thick paste and Endoconcha Sepiae and famotidine adding proper honey, starch is made pill with the method that those skilled in the art all know.
A kind of method for making for the treatment of the Peptic Ulcers pharmaceutical composition of the present invention is:
(1) press Radix Astragali 50-80 weight portion, Endoconcha Sepiae 10-35 weight portion, Radix Paeoniae Alba 25-45 weight portion, Radix Glycyrrhizae 25-45 weight portion, famotidine 0.8-1.3 weight portion is got the raw materials ready.
(2) get the raw materials ready by above-mentioned proportioning, the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae are placed container, add the Radix Astragali, the Radix Paeoniae Alba, the 4-8 of Radix Glycyrrhizae gross weight water doubly is under 80 ℃～121 ℃ temperature, decocted 0.5-3 hour, win time filtrate of filtration adds the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight 3-5 water doubly, again under 80 ℃～121 ℃ temperature in container, decocted 1-2 hour, filter, get the filtrate second time, for the first time filtrate and the filtrate merging second time.When temperature when the temperature of boiling is above, must pressurised extraction.
(3) with the filtrate that merges under 40 ℃～100 ℃ temperature, after being concentrated into the 40-60% of the first and second filtrate cumulative volume that merges, concentrated solution is placed to room temperature, it is the 30-85% percetage by weight that adding ethanol makes its alcoholic acid content, left standstill 8-72 hour, carry out precipitate with ethanol, the precipitate with ethanol after-filtration must contain alcoholic acid concentrated solution.
(4) to containing alcoholic acid concentrated solution, distill, be distilled to ethanol to the greatest extent, continue under 40 ℃～100 ℃ the temperature removing alcoholic acid concentrated solution, being concentrated into its relative density is 1.1-1.5 (50 ℃ of-90 ℃ of surveys).
(5) Endoconcha Sepiae is ground into the Endoconcha Sepiae powder, again with famotidine powder, Endoconcha Sepiae powder and thick paste mix homogeneously, under 60 ℃～80 ℃ temperature, oven dry is ground into the pharmaceutical composition that powder becomes the treatment Peptic Ulcers.
When getting the raw materials ready, press Radix Astragali 60-70 weight portion, Endoconcha Sepiae 15-21 weight portion, Radix Paeoniae Alba 30-40 weight portion, Radix Glycyrrhizae 30-40 weight portion, famotidine 0.8-1.1 weight portion is good.
The Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae are decocted with water secondary, first and second time filtrate is merged, the filtrate that merges is concentrated into the 40-60% of merging filtrate cumulative volume, concentrated solution is placed to room temperature, said room temperature is 15 ℃-25 ℃.
Adding concentration of ethanol when precipitate with ethanol is advisable with the 90-100% percetage by weight, after adding the ethanol of above-mentioned concentration 90-100%, making its alcoholic acid content is the 30-85% percetage by weight, again so that its alcoholic acid content be advisable for the 65-75% percetage by weight, static 8-72 hour, again with static 24-48 hour for well, distillation obtains ethanol behind the precipitate with ethanol, the ethanol that reclaims can reduce production cost for recycling.To containing alcoholic acid concentrated solution, be distilled to ethanol to the greatest extent, continue under 40 ℃-100 ℃ the temperature and concentrate removing alcoholic acid concentrated solution, be concentrated into its relative density 1.2-1.35 (50 ℃ of-90 ℃ of surveys) for well with 80 ℃-100 ℃ again.When Endoconcha Sepiae is pulverized, Endoconcha Sepiae is crushed to the 60-100 order for well.
For the pharmaceutical composition that will treat Peptic Ulcers is made capsule, the starch of the 5%-20% that thick paste and 60-100 purpose Endoconcha Sepiae powder and famotidine powder and thick paste are heavy, behind the mix homogeneously, dry in 60 ℃ of-80 ℃ of oven dry, be ground into fine drug powder, filled hard capsules is advisable to fill No. 1 capsule especially, forms capsule.
The dextrin mix homogeneously of the 5%-20% that thick paste 60-100 purpose Endoconcha Sepiae powder and famotidine and thick paste is heavy is that carrier gas is spray dried to dissolved granule with the nitrogen of pressure 1Mpa-2.5Mpa.
Also thick paste and the Mel of 60-100 purpose Endoconcha Sepiae powder and famotidine and thick paste 5%-50% heavily and the starch mix homogeneously of the 5%-20% that thick paste weighs can be made pill.
Check:
This pharmaceutical composition should meet the regulation of every regulation and Ministry of Public Health " medicine sanitary standard " under Chinese Pharmacopoeia version appendix in 2000 the II item.
Differentiate:
1, it is a small amount of to get this product content, and adding dilute hydrochloric acid has bubble to produce.
2, get this product content 0.5 gram, add 10 milliliters of methanol, placement is spent the night, and filters, and gets 1 milliliter of filtrate, water bath method, and with a small amount of glacial acetic acid dissolved residue, 0.5 milliliter of adding acetic anhydride-concentrated sulphuric acid reagent (19: 1), color changes redness-cyan-green into by Huang.
Character: the content of this pharmaceutical composition is the yellowish-brown powder, sweet, little hardship of distinguishing the flavor of.
Function with cure mainly: boosting qi and nourishing yin, hemostasis hemopoietic, relieving spasm to stop pain.Be used for stomach, duodenal ulcer, hemorrhage; Various stomach, duodenitis.
Usage and consumption: every day for oral administration 2 times, 2-4 of every days.
Specification, every bottle 24 capsules, the present dosage of the Radix Astragali is equivalent to 0.625 gram/grain.Endoconcha Sepiae: present dosage is 0.2083 gram/grain, the Radix Paeoniae Alba: current dose is 0.3125 gram/grain, Radix Glycyrrhizae: current dose is 0.3125 gram/grain, famotidine: dosage is the 10mg/ grain.
Storage: sealing, put shady and cool dry place and preserve, be valid for one year half.
This medicine composite for curing Peptic Ulcers capsule (the flat capsule of ulcer) acute toxicity test;
Experimental animal
20 of Kunming kind white mice, body weight 20 ± 2 grams, male and female half and half.
2, the preparation of test sample
Get this product content 10 gram, add 2%CMC (Carboxymethyl Cellulose, carboxymethyl cellulose) and be dissolved into 50 milliliters, be i.e. 0.2 grams per milliliter, every milliliter of symphysis medicine 0.86 gram.
3, experimental result
Get 20 of healthy mices, irritate 0.8 milliliter in stomach/only, observe mice diet and active situation every day 2 times after the perfusion.Continue to observe 7 days, the result shows that diet and movable no abnormal does not also have animal dead after the mice administration.Mice is to the dosis tolerata of this product be equivalent to be grown up 779 times of clinical consumption.
With the medicament composition capsule agent (ulcer capsule) of treatment Peptic Ulcers of the present invention, the 130 routine clinical observations of treatment gastric and duodenal ulcers have been carried out in Xinyang, Henan Province central hospital.
Gastric and duodenal ulcers belongs to " gastric abscess " category in motherland's medical science.The court's self-control Chinese medicine and western medicine compound preparation ulcer capsule has been obtained doctors and patients' consistent favorable comment in the long-term clinical practice of treatment gastric and duodenal ulcers.The author adopts ulcer capsule for treating gastric and duodenal ulcers 130 examples (treatment group), and treats 60 examples (matched group) with the Western medicine famotidine and carried out paired observation, now is reported as follows:
1. clinical data
1.1 physical data
130 examples are organized in treatment, male 72 examples, women 58 examples, gastric ulcer person 49 examples wherein, duodenal ulcer person 81 examples, age 16-68 year, the course of disease 4 months-10 years, average out to 6 years.In matched group 60 examples, male 36 examples, women 24 examples, gastric ulcer person 17 examples wherein, duodenal ulcer person 43 examples, age 17-66 year, average 42 years old, the course of disease 3 months-8 years.
1.2 case choice criteria
All cases all are diagnosed as gastric ulcer or duodenal ulcer through gastroscope, and the patient enters this and tests and withdrew all medicine for ulcer in preceding 2 days.The queuing standard comprises takes nonsteroidal anti inflammatory medicine or 17-hydroxy-11-dehydrocorticosterone, and complex ulcer merges pyloric obstruction, and the ulcer active hemorrhage has stomach and operation on duodenum history, and disease patients such as severe cardiac, brain, lung, liver, kidney are arranged.
2. Therapeutic Method
2.1 the flat capsule of oral ulcer is organized in treatment, 3/time, 2 times/every day, 4 weeks were a course of treatment.
2.2 30 milligrams of the oral famotidines of matched group, 2 times/every day, 4 weeks were a course of treatment, and two groups all in 4 week of treatment back check gastroscope.
3. therapeutic outcome
3.1 criterion of therapeutical effect is cured: clinical symptom disappearance, ulcer cicatrization, ulcer healing, produce effects: symptom is clearly better, and ulcer heals substantially, and effectively: symptom makes moderate progress, the ulcer area is contracted to former more than 50%, and is invalid: symptom does not have improvement, and ulcer surface does not have and dwindles.
3.2 treatment is organized in 130 examples, cures 119 examples, accounts for 91.5%; In matched group 60 examples, cure 46 examples, accounting for 76.7%, two group relatively has significant differences (P＜0.01).Two groups of clinical efficacies of result are referring to table 1
Table 1 liang group clinical efficacy relatively
| n | Cure | Produce effects | Effectively | Total effective rate | |
| Invalid | 0 | ||||
| The treatment group | 130 | ?119 | ?9 | ?2 | ?100％ |
| Matched group | 60 | ?46 | ?8 | ?6 | ?100％ |
Treatment group as calculated is respectively cure rate 91.54%, obvious effective rate 6.92%, and effective percentage 1.54%, matched group are respectively cure rate 76.69%, obvious effective rate 13.33%, effective percentage 10%.Said total effective rate is a cure rate, obvious effective rate, efficient summation.
4. model case
Huang, the man, first visit in August, 2002, the patient is hunger property epigastrium pain in this year, alleviates after meal, accompany uncomfortable in chest indigestion and loss of appetite, because of tired weak, diseases such as pantothenic acid, tongue is dark red, yellow fur is thick, moderate pulse is sliding, is diagnosed as duodenal ulcer (0.8 * 0.8 centimetre) through gastroscopy.Give 3/time of the flat capsules of ulcer, 2 times/every day, week back further consultation, pain, transference cures such as pantothenic acid, yellow thick fur disappears gradually.Continue to serve on three weeks back check gastroscope, the duodenal bulbar ulcer healing.
Cognition in clinical course is that used ulcer capsule is to be made up of the Radix Astragali, Endoconcha Sepiae, the Radix Paeoniae Alba, Radix Glycyrrhizae and famotidine etc.Reuse the Radix Astragali in the side, get its invigorating the spleen and replenishing QI, the merit of taking the photograph blood that nourishes blood is our monarch drug, Endoconcha Sepiae light weight such as powder, per os are gone into the blood network that stomach directly becomes impaired, its puckery holding back of property and stopping blooding, but its saline taste softening the hard mass dissipating blood stasis and stop blooding and do not stay the stasis of blood can be held back sour stomach function regulating, relieving gastric hyperacidity to alleviate stomachache, Radix Paeoniae Alba picric acid is slightly cold, the energy nourishing YIN and benefiting blood, relieving spasm to stop pain, Radix Glycyrrhizae is sweet flat, also can relieving spasm to stop pain, invigorating the spleen and replenishing QI.Radix Paeoniae Alba sour in the mouth, it is the purest to get wooden gas, the Radix Glycyrrhizae sweet in the mouth, it is the thickest to get native gas, and two medicines are associated with, and the wonderful of sour and sweet drugs can transforme into YIN arranged, preserving YIN with astringents and nourishing blood, the merit of relieving spasm to stop pain.All medicines share, more associate with famotidine, thus the tool boosting qi and nourishing yin, hemostasia and promoting granulation, the effect of relieving spasm to stop pain has good effect in order to treatment gastric and duodenal ulcers etc.
The pharmaceutical composition of treatment Peptic Ulcers of the present invention and the advantage of method for making are: 1 pharmaceutical composition proportioning of the present invention is simple, cost is low, more owing to the Radix Astragali, Endoconcha Sepiae, the Radix Paeoniae Alba, Radix Glycyrrhizae and famotidine are associated with, and diseases such as treatment gastric and duodenal ulcers have good effect.Than treatment gastric ulcer of the prior art, the cure rate of the Chinese medicine composition of duodenal ulcer, the total effective rate height, than the cure rate of independent use famotidine, total effective rate is also high.It can treat various gastritis, duodenitis again.Its toxicity is taken safety for a short time.
2, because pharmaceutical composition of the present invention can be made various forms solid dosage formss such as capsule, electuary, pill, be easy to store, transport, taking convenience carries taking convenience especially on the road.
3, preparation of drug combination technology of the present invention, equipment are simple, investment is low, easy to utilize.
The specific embodiment
Below with pharmaceutical composition and the method for making thereof of specific embodiment to treatment Peptic Ulcers of the present invention, be further described, will help pharmaceutical composition of the present invention, method for making and advantage thereof are had a better understanding.But embodiment does not limit protection scope of the present invention.Protection scope of the present invention is decided by claim.
Embodiment 1
The treatment medicine for ulcer compositions of present embodiment is 60 kilograms of the Radixs Astragali, 21 kilograms of Endoconcha Sepiaes, 30 kilograms of the Radix Paeoniae Albas, 30 kilograms in Radix Glycyrrhizae, 1.0 kilograms of famotidines.The Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae are decocted with water, and filtrate concentrates, and through precipitate with ethanol, removes alcoholic acid concentrated solution, is condensed into thick paste, and with thick paste and Endoconcha Sepiae powder and famotidine powder mix homogeneously, dry, pulverizing forms the pharmaceutical composition of treatment Peptic Ulcers.
Method for making:
(1) gets the raw materials ready for 1.0 kilograms by 60 kilograms of the Radixs Astragali, 21 kilograms of Endoconcha Sepiaes, 30 kilograms of the Radix Paeoniae Albas, 30 kilograms in Radix Glycyrrhizae, famotidine.
(2) get the raw materials ready by above-mentioned proportioning, the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae are placed container, add 6 times water of the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight, under 121 ℃ temperature, decocted 2 hours, filter.Win time filtrate adds 4 times water of the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight again in container, decocted 1.5 hours under 121 ℃ temperature, filters.Get filtrate for the second time.Filtrate and filtrate merging for the second time for the first time.
(3) with the filtrate that merges, under 100 ℃ temperature, be concentrated into 50% of first and second time merging filtrate cumulative volume, concentrated solution is placed to room temperature, adding concentration is the ethanol of 95% percetage by weight, and making wherein alcoholic acid content is 70% percetage by weight, leaves standstill 24 hours, carry out precipitate with ethanol, the precipitate with ethanol after-filtration must contain alcoholic acid concentrated solution.
(4) will contain alcoholic acid concentrated solution, and be distilled to ethanol to removing ethanol to the greatest extent, and continue under 100 ℃ the temperature removing alcoholic acid concentrated solution, being concentrated into its relative density is the thick paste of 1.20 (50 ℃ of surveys).
(5) Endoconcha Sepiae is ground into powder, again with Endoconcha Sepiae powder, famotidine powder and thick paste mix homogeneously, under 70 ℃ temperature, dry, be ground into fine powder.
Embodiment 2
The proportioning of pharmaceutical composition of the present utility model and method for making, substantially with embodiment 1, only different is that Endoconcha Sepiae is crushed to 100 orders, again with thick paste and famotidine powder, behind heavy 10% the starch mix homogeneously of 100 order Endoconcha Sepiae powder and thick paste, after the drying, be ground into fine powder and fill capsulae vacuus formation capsule No. 1 under 70 ℃ the temperature.
Embodiment 3
The proportioning of the pharmaceutical composition of present embodiment and method for making are substantially with embodiment 1, only different is that Endoconcha Sepiae is crushed to 100 orders, 6% again that thick paste and 100 order Endoconcha Sepiae powder and famotidine and thick paste is heavy dextrin mix homogeneously, nitrogen with pressure 2.0Mpa is carrier, is spray dried to dissolved granule.
Embodiment 4
The proportioning of the pharmaceutical composition of present embodiment and method for making are substantially with embodiment 1, only different is, Endoconcha Sepiae is crushed to 100 orders, and again with thick paste and 100 purpose Endoconcha Sepiae powder, famotidine and 30% heavy Mel of thick paste, 20% the starch mix homogeneously that thick paste is heavy is made pill.
Embodiment 5
The pharmaceutical composition of present embodiment and method for making are substantially with embodiment 1, and only different is 50 kilograms of stilbenes, 10 kilograms of Endoconcha Sepiaes, 25 kilograms of the Radix Paeoniae Albas, 25 kilograms in Radix Glycyrrhizae, 0.8 kilogram of famotidine.
Its method for making is to get the raw materials ready by said ratio.Add the water of 4 times of the Radixs Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight, under 100 ℃ temperature, decocted 0.5 hour, filter, add 3 times water of the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight again, under 100 ℃ temperature, decocted 1 hour, filter.With the filtrate that merges under 40 ℃ temperature, be concentrated into merging the filtrate cumulative volume 40% after, be placed to room temperature, adding concentration is the ethanol of 90% percetage by weight, making its alcoholic acid content is 30% percetage by weight, static 72 hours.Carry out precipitate with ethanol.Ethanol is removed in the row distillation in the time of will containing alcoholic acid concentrated solution.Continue under 40 ℃ the temperature and be concentrated into the thick paste that relative density is 1.1 (90 ℃ of surveys) removing alcoholic acid concentrated solution.Endoconcha Sepiae is ground into 60 purpose Endoconcha Sepiae powder.20% the starch mix homogeneously that thick paste and 60 order Endoconcha Sepiae powder, famotidine powder and thick paste is heavy, dry, be ground into fine powder under 80 ℃ temperature, fills capsulae vacuus formation capsule No. 1.
Embodiment 6
The pharmaceutical composition of present embodiment and method for making, substantially with embodiment 1, only different is 80 kilograms of the Radixs Astragali, 35 kilograms of Endoconcha Sepiaes, 45 kilograms of the Radix Paeoniae Albas, 45 kilograms in Radix Glycyrrhizae, 1.3 kilograms of famotidines.
Its method for making is got the raw materials ready by above-mentioned proportioning, adds the water of 8 times of the Radixs Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight, under 80 ℃ temperature, decocts 3 hours filtration.Add the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae again and must measure 5 times water, under 80 ℃ temperature, decocted 2 hours, filter.The filtrate that merges in 60% of 95 ℃ of filtrate cumulative volumes that are concentrated into merging, is placed to room temperature, and adding concentration is the ethanol of 100% percetage by weight, and making its alcoholic acid content is 85% percetage by weight, static 8 hours.To contain alcoholic acid concentrated solution and distill, remove ethanol.Continue under 90 ℃ the temperature and be concentrated into the thick paste that relative density is 1.5 (60 ℃ of surveys) removing alcoholic acid concentrated solution.Endoconcha Sepiae is crushed to 80 orders.With 5% the starch mix homogeneously that thick paste and 80 purpose Endoconcha Sepiae powder and famotidine and thick paste get, dry under 75 ℃ the temperature, be ground into fine powder, fills No. 1 capsulae vacuus, the formation capsule.
Embodiment 7
The pharmaceutical composition of present embodiment and method for making, substantially with embodiment 1, only different is 65 kilograms of the Radixs Astragali, 15 kilograms of Endoconcha Sepiaes, 40 kilograms of the Radix Paeoniae Albas, 40 kilograms in Radix Glycyrrhizae, 1.1 kilograms of famotidines.
Its method for making is: get the raw materials ready by said ratio, add the water of 5 times of the Radixs Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight, under 100 ℃ temperature, decocted 2.5 hours filtration.4 times the water that adds the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae weight again under 100 ℃ temperature, decocted 2 hours, filtered.With the filtrate that merges, in the filtrate cumulative volume that is concentrated into merging under 100 ℃ the temperature 50% after, be placed to room temperature, adding concentration is the ethanol of 95% percetage by weight, making its alcoholic acid content is 75% percetage by weight, static 48 hours.To contain alcoholic acid concentrated solution distills and removes ethanol.Continue under 100 ℃ the temperature and be concentrated into the thick paste that relative density is 1.35 (50 ℃ of surveys) removing alcoholic acid concentrated solution.Endoconcha Sepiae is ground into 100 purpose Endoconcha Sepiae powder.Thick paste and Endoconcha Sepiae powder, famotidine powder and thick paste are weighed 7% starch mix homogeneously, dry, be ground into fine powder under 80 ℃ temperature, fill No. 1 the hungry area wafer.
Embodiment 8
The pharmaceutical composition of present embodiment and method for making, substantially with embodiment 1, only different is 70 kilograms of the Radixs Astragali, 21 kilograms of Endoconcha Sepiaes, 35 kilograms of the Radix Paeoniae Albas, 35 kilograms in Radix Glycyrrhizae, 0.8 kilogram of famotidine.
Its method for making is: get the raw materials ready by above-mentioned proportioning, add 7 times water of the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight, decocted 2.5 hours under 121 ℃ temperature, filter.4.5 times the water that adds the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight again under 121 ℃ temperature, decocted 2 hours, filtered.The filtrate that merges is concentrated into 45% of merging filtrate cumulative volume under 100 ℃ temperature, is placed to room temperature.Adding concentration is the ethanol of the percent of 95% weight, and making its alcoholic acid content is 65% percetage by weight, static 36 hours.To contain alcoholic acid concentrated solution distills and removes ethanol.Continue under 100 ℃ the temperature and be concentrated into the thick paste that relative density is 1.25 (50 ℃ of surveys) removing alcoholic acid concentrated solution.Endoconcha Sepiae is crushed to 100 orders,, under 60 ℃ of temperature, is dried and crushed into fine powder, fill No. 1 capsulae vacuus, form capsule the Endoconcha Sepiae powder of thick paste and 100 and the starch mix homogeneously of famotidine powder and thick paste 15%.
Claims (9)
1. a pharmaceutical composition for the treatment of Peptic Ulcers is characterized in that,
Contain Radix Astragali 50-80 weight portion, Endoconcha Sepiae 10-35 weight portion, Radix Paeoniae Alba 25-45 weight portion, Radix Glycyrrhizae 25-45 weight portion, famotidine 0.8-1.3 weight portion, the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae are decocted with water, and filtrate concentrates, precipitate with ethanol, remove alcoholic acid concentrated solution, be condensed into thick paste, with thick paste and Endoconcha Sepiae powder and famotidine powder mix homogeneously, the pharmaceutical composition that drying and crushing forms.
2. according to a kind of pharmaceutical composition for the treatment of Peptic Ulcers of claim 1, it is characterized in that, contain Radix Astragali 60-70 weight portion, Endoconcha Sepiae 15-21 weight portion, Radix Paeoniae Alba 30-40 weight portion, Radix Glycyrrhizae 30-40 weight portion, famotidine 0.8-1.1 weight portion.
3. a method for making for the treatment of the pharmaceutical composition of Peptic Ulcers is characterized in that,
(1) presses Radix Astragali 50-80 weight portion, Endoconcha Sepiae 10-35 weight portion, Radix Paeoniae Alba 25-45 weight portion, Radix Glycyrrhizae 25-45 weight portion, famotidine 0.8-1.1 weight portion;
(2) get the raw materials ready by said ratio, the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae are placed container, add the 4-8 water doubly of the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight, under 80 ℃～121 ℃ temperature, decocted 0.5-3 hour, win time filtrate of filtration, in container, add the Radix Astragali, the Radix Paeoniae Alba, Radix Glycyrrhizae gross weight 3-5 water doubly again, under 80 ℃～121 ℃ temperature, decocted 1-2 hour, filter filtrate for the second time, for the first time filtrate and for the second time filtrate merge;
(3) with the filtrate that merges under 40 ℃～100 ℃ temperature, after being concentrated into the 40-60% of the first and second filtrate cumulative volume that merges, concentrated solution is placed to room temperature, it is the 30-85% percetage by weight that adding ethanol makes its alcoholic acid content, left standstill 8-72 hour, carry out precipitate with ethanol, the precipitate with ethanol after-filtration must contain alcoholic acid concentrated solution;
(4) to containing alcoholic acid concentrated solution, be distilled to ethanol to the greatest extent, will remove alcoholic acid concentrated solution, continue under 40 ℃～100 ℃ the temperature, be concentrated into its relative density and be 1.1～1.5 thick paste;
(5) Endoconcha Sepiae is ground into the Endoconcha Sepiae powder, again with the famotidine powder, Endoconcha Sepiae powder and thick paste are mixed even, and be under 60 ℃～80 ℃ temperature, dry, be ground into powder.
4. according to a kind of method for making for the treatment of the pharmaceutical composition of Peptic Ulcers of claim 3, it is characterized in that it is the 65-75% percetage by weight that adding ethanol makes its alcoholic acid content, leaves standstill 24-48 hour.
5. according to a kind of method for making for the treatment of the pharmaceutical composition of Peptic Ulcers of claim 3, it is characterized in that, remove alcoholic acid concentrated solution, continue under 80 ℃～100 ℃ the temperature, being concentrated into its relative density is 1.2-1.35.
6. according to a kind of method for making for the treatment of the pharmaceutical composition of Peptic Ulcers of claim 3, it is characterized in that, Endoconcha Sepiae is crushed to the 60-100 order.
7. according to a kind of method for making for the treatment of the pharmaceutical composition of Peptic Ulcers of claim 3, it is characterized in that, the starch of thick paste and 60-100 purpose Endoconcha Sepiae powder and thick paste 5%-20% heavily, behind the mixture, in 60～80 ℃ of dryings, be ground into fine drug powder, filled hard capsules.
8. according to a kind of method for making for the treatment of the pharmaceutical composition of Peptic Ulcers of claim 3, it is characterized in that, the dextrin mix homogeneously of the 5%-20% that thick paste and 60-100 purpose Endoconcha Sepiae powder and famotidine and thick paste is heavy is that carrier gas is spray dried to dissolved granule with the nitrogen of pressure 1Mpa-2.5Mpa.
9. according to a kind of method for making for the treatment of the pharmaceutical composition of Peptic Ulcers of claim 3, it is characterized in that, with thick paste and the Mel of 60-100 purpose Endoconcha Sepiae powder and Famotidine and thick paste 5%-50% heavily and the starch of the 5%-20% that thick paste weighs, mix homogeneously is made pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031371531A CN1237994C (en) | 2003-06-06 | 2003-06-06 | Medicine composition for preparing canker and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031371531A CN1237994C (en) | 2003-06-06 | 2003-06-06 | Medicine composition for preparing canker and preparing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1552409A true CN1552409A (en) | 2004-12-08 |
| CN1237994C CN1237994C (en) | 2006-01-25 |
Family
ID=34323515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031371531A Expired - Fee Related CN1237994C (en) | 2003-06-06 | 2003-06-06 | Medicine composition for preparing canker and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1237994C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825612A (en) * | 2015-05-27 | 2015-08-12 | 苗怡文 | Medicine composition for treating gastritis and method for manufacturing medicine composition |
| CN106943418A (en) * | 2017-05-05 | 2017-07-14 | 昆明生达制药有限公司 | A kind of composition and preparation method and purposes for treating enterogastric diseases |
| CN108653381A (en) * | 2018-07-11 | 2018-10-16 | 合肥华盖生物科技有限公司 | A kind of Chinese and western medicinal composition preparation method for treating chronic gastric ulcer |
| CN110812442A (en) * | 2019-12-06 | 2020-02-21 | 湖北威仕生物药业股份有限公司 | Preparation method and application of five-ginseng-astragalus oral solution |
| CN115154551A (en) * | 2022-07-27 | 2022-10-11 | 黑龙江迪龙制药有限公司 | Pharmaceutical composition containing famotidine for relieving stomach discomfort and preparation method thereof |
-
2003
- 2003-06-06 CN CNB031371531A patent/CN1237994C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825612A (en) * | 2015-05-27 | 2015-08-12 | 苗怡文 | Medicine composition for treating gastritis and method for manufacturing medicine composition |
| CN106943418A (en) * | 2017-05-05 | 2017-07-14 | 昆明生达制药有限公司 | A kind of composition and preparation method and purposes for treating enterogastric diseases |
| CN108653381A (en) * | 2018-07-11 | 2018-10-16 | 合肥华盖生物科技有限公司 | A kind of Chinese and western medicinal composition preparation method for treating chronic gastric ulcer |
| CN110812442A (en) * | 2019-12-06 | 2020-02-21 | 湖北威仕生物药业股份有限公司 | Preparation method and application of five-ginseng-astragalus oral solution |
| CN110812442B (en) * | 2019-12-06 | 2022-02-08 | 湖北威仕生物药业股份有限公司 | Preparation method and application of five-ginseng-astragalus oral solution |
| CN115154551A (en) * | 2022-07-27 | 2022-10-11 | 黑龙江迪龙制药有限公司 | Pharmaceutical composition containing famotidine for relieving stomach discomfort and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1237994C (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857618A (en) | Chinese medicine preparation for reducing sugar | |
| CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN101049340A (en) | A pharmaceutical composition for treating vitiligo and its preparation method | |
| CN1205974C (en) | Thirty-six ingredients capsule for treating diabetes | |
| CN1237994C (en) | Medicine composition for preparing canker and preparing method thereof | |
| CN1742919A (en) | Shuerjing Chinese medicine preparation and preparing method thereof | |
| CN1168488C (en) | Chinese medicinal preparation for treating pyretic stranguria | |
| CN1465387A (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1246016C (en) | Compound formulation of traditional Chinese medicine for climacteric syndrome and preparation method | |
| CN1079396A (en) | Intelligence-enhancing pharmaceutical preparation | |
| CN102836315A (en) | Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof | |
| CN102274428A (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN1263490C (en) | Yang reinforcing medicine and its preparation method | |
| CN102362879B (en) | Traditional Chinese herbal medicinal preparation for relieving ulcer by inhibiting gastric acid and preparation method thereof | |
| CN1081926C (en) | Chinese medicine for preventing tumour and use in making drug | |
| CN1446550A (en) | Chinese herbal medicine and for treating acute rhinitis and chronic rhinitis as well as its preparing method | |
| CN101129997A (en) | Radix curcumae oral liquid for relieving exterior syndrome | |
| CN107362296B (en) | Medicine for treating benign tumor of skin and preparation method thereof | |
| CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN1504231A (en) | Medicine for tumour | |
| CN1140292C (en) | Medicine for increasing leucocyte and its preparation | |
| CN1189207C (en) | Chinese medicinal composition for improving human immunity and its preparation method | |
| CN1239179C (en) | Chinese medicine for treating diabetes and preparation method therefor | |
| CN1068219C (en) | Slow-released analgesic suppository and its preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |